Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer

SIMPLE SUMMARY: Recurrent ovarian cancer is difficult to treat due to the development of chemotherapy resistance. This resistance develops through multiple mechanisms to include the avoidance of cell death by cancer cells. Prior studies have shown birinapant, a second mitochondrial activator of casp...

詳細記述

保存先:
書誌詳細
出版年:Cancers (Basel)
主要な著者: Noonan, Anne M., Cousins, Amanda, Anderson, David, Zeligs, Kristen P., Bunch, Kristen, Hernandez, Lidia, Shibuya, Yusuke, Goldlust, Ian S., Guha, Rajarshi, Ferrer, Marc, Thomas, Craig J., Annunziata, Christina M.
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765376/
https://ncbi.nlm.nih.gov/pubmed/33334024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123784
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料